Table 5.
Adverse event | |
---|---|
Neuropathy | 28 (42%) |
PSN | 9 (13%) |
PMN | 4 (6%) |
Both PMN and PSN | 15 (22%) |
Neutropenia | 20 (30%) |
Thrombocytopenia | 8 (12%) |
Anemia | 6 (9%) |
Pulmonary toxicity | 6 (9%) |
Transaminitis | 5 (7%) |
Infusion reaction | 4 (6%) |
Nausea/vomiting | 3 (4%) |
Cardiotoxicity | 2 (3%) |
Secondary malignancy | 1 (2%) |